-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pulmonary hypertension (POPH) due to portal hypertension is a complication of cirrhosis that can lead to right ventricular failure and death
Autopsy records of 824 subjects with cirrhosis were selected to identify pulmonary vascular lesions
ET-B reactivity in the lung endothelium and smooth muscle was identified
ER-β reactivity was observed in 4 subjects (26.
Research Implications:
First, the prevalence of histopathological evidence of pulmonary hypertension in cirrhosis is 3.
References:
Crnkovic S, Valzano F, Fließer E, Gindlhuber J, Thekkekara Puthenparampil H, Basil MC, Morley MP, Katzen J, Gschwandtner E, Klepetko W, Cantu E, Wolinski H, Olschewski H, Lindenmann J, Zhao YY, Morrisey EE, Marsh LM, Kwapiszewska G.